bluebird bio Provides Operational and Business Update and Reports First Quarter 2020 Financial Results

Go back to bluebird bio Provides Operational and Business Update and Reports First Quarter 2020 Financial Results

bluebird bio (BLUE) Reports Q1 Loss of $3.64/sh

May 11, 2020 7:14 AM EDT

bluebird bio (NASDAQ: BLUE) reported Q1 EPS of ($3.64), versus ($2.99) reported last year. Revenue for the quarter came in at $21.9 million, versus $12.5 million reported last year.

For earnings history and earnings-related data on bluebird bio (BLUE) click here.

... More